Fujieda, Yuichiro https://orcid.org/0000-0003-4705-341X
Doi, Mototsugu
Asaka, Takuya
Ota, Masahiro
Hisada, Ryo
Ohnishi, Naoki
Kono, Michihiro
Kameda, Hiraku
Nakazawa, Daigo
Kato, Masaru
Amengual, Olga
Takahata, Masahiko
Yasuda, Shinsuke
Kitagawa, Yoshimasa
Atsumi, Tatsuya
Article History
Received: 15 June 2019
Accepted: 2 February 2020
First Online: 19 February 2020
Compliance with ethical standards
:
: T. Atsumi reports personal fees from Chugai, during the conduct of the study; grants and personal fees from Astellas, grants and personal fees from Takeda, grants and personal fees from Mitsubishi Tanabe, grants and personal fees from Chugai, grants and personal fees from Pfizer, grants from Daiichi Sankyo, grants from Otsuka, personal fees from Eisai, personal fees from AbbVie, outside the submitted work. S. Yasuda reports grants and speaker’s fee from Bristol-Myers Squibb Co., Speaker’s fee from Chugai, Mitsubishi Tanabe, outside the submitted work. M. Kato reports grants from GSK, grants from Actelion, outside the submitted work. The other authors state that they have no conflict of interest. M. Takahata reports grants and speaker’s fee from Chugai, Eisai, DePuy Spine Inc, and Medtronic, outside the submitted work. The other authors state that they have no conflict of interest.
: This study was performed in accordance with the Declaration of Helsinki and the principles of Good Clinical Practice. Study approval was obtained from the Local Ethics Committee (approval number: 017-0029).